Notified on 9 February 2005, this merger consists of the acquisition by Angelini Farmacêutica, Lda, (Angelini Farmacêutica), from Aventis Pharma, Lda (Aventis Pharma) and Laboratórios Roussel, Lda, (Laboratórios Roussel), of the rights and obligations relating to the marketing of the product Adalgur N®, in Portugal.